Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2001;60:956-961; doi:10.1136/ard.60.10.956
Copyright © 2001 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2001;60:956-961 ( October )

Extended report

Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample N J Wilesa, D G I Scottb, E M Barrettc, P Merryb, E Arieb, K Gaffneyb, A J Silmana, D P M Symmonsa

a ARC Epidemiology Unit, University of Manchester Medical School, Oxford Road, Manchester M13 9PT, UK, b Department of Rheumatology, Norfolk and Norwich Hospital, Norfolk NR1 3SR, UK, c Norfolk Arthritis Register, St Michael's Hospital, Aylsham, Norfolk NR11 6NA, UK

Correspondence to: Professor Symmons deborah.symmons{at}man.ac.uk

Accepted for publication 27 March 2001

BACKGROUND---Treatment, and therefore outcome, of rheumatoid arthritis (RA) will improve in the next few years. However, improvement in outcome can only be judged against the probability of certain outcomes with current conventional treatment.
AIM---To document the five year outcome of RA in the late 1990s.
SETTING---Norfolk Arthritis Register (NOAR).
DESIGN---Longitudinal observational cohort study.
METHODS---318 patients with recent onset inflammatory polyarthritis recruited by NOAR in 1990-91 completed five years of follow up. Four groups were assessed: the whole cohort, all those referred to hospital, those who satisfied criteria for RA at baseline, and those referred to hospital who satisfied criteria for RA at baseline. Outcome was assessed with a visual analogue scale for pain, the Health Assessment Questionnaire (HAQ), and the Short Form-36 (SF-36).
RESULTS---Of the RA hospital attenders, 50% had a visual analogue scale pain score of 5 cm or less and an HAQ score of 1.125 or less. SF-36 scores were reduced in all domains. Results are presented as cumulative percentages.
CONCLUSIONS---These results can be used for comparison and to set targets for improvement.


© 2001 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Soderlin, M. K., Lindroth, Y., Jacobsson, L. T. H. (2007). Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden. Rheumatology (Oxford) 46: 1355-1358 [Abstract] [Full Text]  
  • Pincus, T, Sokka, T, Chung, C P, Cawkwell, G (2006). Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials. Ann Rheum Dis 65: 878-883 [Abstract] [Full Text]  
  • Kavanaugh, A (2005). Health economics: implications for novel antirheumatic therapies. Ann Rheum Dis 64: iv65-iv69 [Abstract] [Full Text]  
  • Barkham, N., Kong, K. O., Tennant, A., Fraser, A., Hensor, E., Keenan, A. M., Emery, P. (2005). The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford) 44: 1277-1281 [Abstract] [Full Text]  
  • Plant, M. J., O'Sullivan, M. M., Lewis, P. A., Camilleri, J. P., Coles, E. C., Jessop, J. D. (2005). What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?. Rheumatology (Oxford) 44: 1181-1185 [Abstract] [Full Text]  
  • (2003). Minerva. BMJ 327: E79-79 [Full Text]  
  • Scott, D. L., Strand, V. (2002). The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database. Rheumatology (Oxford) 41: 899-909 [Abstract] [Full Text]  
  • WOLFE, F, CHOI, H K (2001). Benchmarking and the percentile assessment of RA: adding a new dimension to rheumatic disease measurement. Ann Rheum Dis 60: 994-995 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs